T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
First Internet Bancorp
INBK
$256M
| $268K | ﹤0.01% |
7,697
-5,731
| -43% | -$173K |
|
2477
Vipshop
VIPS
$6.8B
| $267K | ﹤0.01% |
16,071
+513
| +3% | +$8.63K |
|
|
OLO
2478
DELISTED
Olo Inc
OLO
| $265K | ﹤0.01% |
48,240
+4,382
| +10% | +$23.9K |
|
|
VTYX
2479
DELISTED
Ventyx Biosciences
VTYX
| $265K | ﹤0.01% |
48,027
-155,291
| -76% | -$710K |
|
2480
Enact Holdings
ACT
$6.84B
| $264K | ﹤0.01% |
8,461
+1,161
| +16% | +$32.9K |
|
2481
Anavex Life Sciences
AVXL
$303M
| $264K | ﹤0.01% |
51,774
+946
| +2% | +$5.33K |
|
|
CWEN.A
2482
DELISTED
Clearway Energy Class A
CWEN.A
| $264K | ﹤0.01% |
12,250
+1,178
| +11% | +$25.8K |
|
2483
Domo
DOMO
$187M
| $264K | ﹤0.01% |
29,536
+1,180
| +4% | +$12.3K |
|
2484
Repay Holdings
RPAY
$317M
| $264K | ﹤0.01% |
23,911
+3,661
| +18% | +$32.4K |
|
2485
Vita Coco
COCO
$3.77B
| $263K | ﹤0.01% |
+10,736
| New | +$249K |
|
2486
Gevo
GEVO
$401M
| $263K | ﹤0.01% |
341,936
+192,457
| +129% | +$167K |
|
|
KALV
2487
DELISTED
KalVista Pharmaceuticals
KALV
| $263K | ﹤0.01% |
22,142
+944
| +4% | +$12.6K |
|
2488
Lifestance Health
LFST
$4.67B
| $262K | ﹤0.01% |
42,366
+4,681
| +12% | +$31.5K |
|
2489
Origin Bancorp
OBK
$1.69B
| $262K | ﹤0.01% |
8,359
+1,079
| +15% | +$33.5K |
|
2490
Omega Flex
OFLX
$291M
| $262K | ﹤0.01% |
3,687
+111
| +3% | +$7.88K |
|
2491
Transcat
TRNS
$888M
| $262K | ﹤0.01% |
2,347
+284
| +14% | +$30.1K |
|
|
AAN
2492
DELISTED
The Aaron's Company Inc
AAN
| $262K | ﹤0.01% |
34,836
+1,058
| +3% | +$9.9K |
|
2493
Ring Energy
REI
$349M
| $261K | ﹤0.01% |
132,995
+8,792
| +7% | +$13.1K |
|
|
ONTF
2494
DELISTED
ON24
ONTF
| $260K | ﹤0.01% |
36,398
+1,222
| +3% | +$8.88K |
|
2495
Canterbury Park Holding Corp
CPHC
$81.4M
| $258K | ﹤0.01% |
11,379
| – | – |
|
2496
iHeartMedia
IHRT
$464M
| $258K | ﹤0.01% |
123,339
+7,567
| +7% | +$17.8K |
|
2497
Aspen Aerogels
ASPN
$504M
| $257K | ﹤0.01% |
14,580
+1,938
| +15% | +$28.6K |
|
2498
Limbach Holdings
LMB
$527M
| $257K | ﹤0.01% |
6,199
+483
| +8% | +$21K |
|
2499
Kopin
KOPN
$898M
| $256K | ﹤0.01% |
141,800
| – | – |
|
2500
MiMedx Group
MDXG
$612M
| $254K | ﹤0.01% |
32,978
+3,806
| +13% | +$30.6K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.